September 26, 2011

From Frog Skin Cancer Drugs

It seems the road is open towards the cost of cancer treatment is getting closer. The scientists led by Prof.. Chris Shaw from Queen's School of Pharmacy, England managed to identify two proteins frogs to cure cancer.

Two waxy monkey frog proteins can inhibit blood vessel growth and kill cancer tumors. The research team also found that the fire-bellied toads produce proteins that can stimulate blood vessel growth. This one type of protein can actually help patients recover from injury in a faster time.

"The results of this research has the potential to treat diseases that require blood vessels, improve quickly as wound healing, organ transplants, patients with diabetic wounds, and damage caused by heart disease and stroke," said Professor Shaw.

So far, scientists and drug companies around the world have invested about trillions of dollars to develop drugs that effectively control and regulate blood vessel growth.

However, Prof. disclosed. Shaw, drug discovery efforts that have yet to find bright spots. "Our research goal is to unlock the potential of nature, in this case the frog skin secretions released human suffering can be overcome. We are very confident, natural potential could be a solution to many of our problems in the world. We just need to ask the right questions to find it," he said .

"It is a shame that we have a lot of potential stored in the universe that could potentially be a great cure for cancer. While we do not do anything to get it," he said.

The study won praise in the award the Medical Futures Innovation Awards in London, early last month. Prof. Brian Walker and Dr. Tianbao Chen, the award judging panel, led researchers who praised it to continue their work to the next stage.

"Many great discoveries by accident and ideas dikuak Prof. Shaw is very innovative and interesting to meet our needs. It's also important to recognize that innovation is still in its early stages. It will take much effort to realize this research into clinical therapies," said panel jury.
Posted by at
Labels:

From Frog Skin Cancer Drugs

It seems the road is open towards the cost of cancer treatment is getting closer. The scientists led by Prof.. Chris Shaw from Queen's School of Pharmacy, England managed to identify two proteins frogs to cure cancer.

Two waxy monkey frog proteins can inhibit blood vessel growth and kill cancer tumors. The research team also found that the fire-bellied toads produce proteins that can stimulate blood vessel growth. This one type of protein can actually help patients recover from injury in a faster time.

"The results of this research has the potential to treat diseases that require blood vessels, improve quickly as wound healing, organ transplants, patients with diabetic wounds, and damage caused by heart disease and stroke," said Professor Shaw.

So far, scientists and drug companies around the world have invested about trillions of dollars to develop drugs that effectively control and regulate blood vessel growth.

However, Prof. disclosed. Shaw, drug discovery efforts that have yet to find bright spots. "Our research goal is to unlock the potential of nature, in this case the frog skin secretions released human suffering can be overcome. We are very confident, natural potential could be a solution to many of our problems in the world. We just need to ask the right questions to find it," he said .

"It is a shame that we have a lot of potential stored in the universe that could potentially be a great cure for cancer. While we do not do anything to get it," he said.

The study won praise in the award the Medical Futures Innovation Awards in London, early last month. Prof. Brian Walker and Dr. Tianbao Chen, the award judging panel, led researchers who praised it to continue their work to the next stage.

"Many great discoveries by accident and ideas dikuak Prof. Shaw is very innovative and interesting to meet our needs. It's also important to recognize that innovation is still in its early stages. It will take much effort to realize this research into clinical therapies," said panel jury.